The comments submitted were in response to draft guidance on enhancing the diversity of clinical trial populations, which had been published by FDA in June, 2019.
Submitted comments to FDA
August 05, 2021
Toggle navigation
Toggle navigation
August 05, 2021
The comments submitted were in response to draft guidance on enhancing the diversity of clinical trial populations, which had been published by FDA in June, 2019.